![]() | ![]() |
Formats:
|
||||||||||||||||
Copyright © 2003 European Molecular Biology Organization An SP1-like transcription factor Spr2 acts downstream of Fgf signaling to mediate mesoderm induction 1Department of Biological Sciences and Biotechnology, Protein Sciences Laboratory of the MOE, Tsinghua University, Beijing 100084, China and 2Institute of Neuroscience, University of Oregon, Eugene, OR 97403, USA 3Corresponding author e-mail: mengam/at/mail.tsinghua.edu.cn Received June 2, 2003; Revised September 30, 2003; Accepted October 2, 2003. This article has been cited by other articles in PMC.Abstract Fgf signaling, mediated in part by the transcription factor Brachyury/Xbra/Ntl, plays important roles in mesoderm formation during the early development of vertebrate embryos. We have identified a zebrafish gene, spr2, which encodes a member of the Sp1-like transcription factor family. spr2 is expressed in both hypoblast and epiblast cells during late blastulation/early gastrulation, and in some mesodermal and neural tissues at later stages. Injection with spr2 mRNA enhances ntl expression and alleviates the inhibitory effect on ntl of XFD, a Xenopus dominant-negative FGF receptor. In contrast, morpholino- mediated knockdown of Spr2 activity inhibits ntl expression and reduces the inductive effect of Fgfs on ntl. We also demonstrate that Fgf signaling relays mesoderm induction activity of Nodal signaling and Spr2 is involved in this signal relay process. Furthermore, the correct spatial expression of spr2 requires Nodal, Fgf and Wnt signals. We suggest that expression of spr2 is an immediate-early response to mesoderm induction by Fgfs, which in turn regulates the expression of effector genes involved in the development of mesodermal tissues. Keywords: fibroblast growth factor/mesoderm/SP1-like transcription factor/zebrafish Introduction The formation and patterning of the three germ layers of vertebrate embryos are highly complex processes that are regulated by extensive interactions between several inductive signals. The mesoderm is induced in amphibians by signals derived from the endoderm (Nieuwkoop, 1969), and in zebrafish by signals produced both by the yolk syncytial layer and the yolk cell itself (Mizuno et al., 1996; Chen and Kimelman, 2000). Molecular and genetic studies have identified VegT, a T-box transcription factor (Zhang et al., 1998; Kofron et al., 1999), as an early endogenous mesoderm inducer in Xenopus, which is maternally produced and vegetally localized. Previous studies in Xenopus suggest that VegT activates the expression of nodal-related genes in the endoderm, which in turn induce the formation of mesoderm (Clements et al., 1999; Kofron et al., 1999; Agius et al., 2000). In addition, mice deficient in Nodal fail to form the primitive streak and lack most mesodermal cells (Zhou et al., 1993; Conlon et al., 1994). Furthermore, in zebrafish, the simultaneous loss-of-function of two nodal genes, squint (sqt) and cyclops (cyc), result in embryos that are missing most of the mesodermal tissues (Feldman et al., 1998). Thus, Nodal signal is believed to be a universal, well conserved, mesoderm inducer during vertebrate embryogenesis. Fgf signals are also known to play a key role in the induction of the mesoderm and, like Nodal, its role in mesoderm induction appears to be conserved in vertebrates. Mutant mice lacking Fgf8 are unable to undergo normal gastrulation, leading to loss of mesoderm- and endoderm-derived tissues (Sun et al., 1999). In Xenopus, the addition of Fgf causes animal cap explants to form mesoderm tissues (Kimelman and Kirschner, 1987; Slack et al., 1987), while a dominant-negative Fgf receptor (dnFGFR) can inhibit the formation of the posterior and lateral mesoderm (Amaya et al., 1991, 1993). In zebrafish acerebellar mutants, which carry a mutation in the fgf8 locus, a slight reduction of somatic mesoderm is observed (Reifers et al., 1998). In addition, an inhibition of Fgf receptor signaling in the zebrafish embryos leads to complete loss of both the trunk and tail (Griffin et al., 1995), which also supports a role for Fgf signaling in mesoderm induction. It has been suggested from work in Xenopus that Fgf signals act in a signal relay mechanism to control mesoderm induction, such that the signals enable cells in the marginal zone to be competent for mesoderm induction by TGFβ signals (Cornell and Kimelman, 1994; LaBonne and Whitman, 1994). A well-studied transcription factor that is downstream of Fgf signals is Brachyury, which was first identified in mouse (Herrmann et al., 1990; Wilkinson et al., 1990). Mutant mice homologous for the Brachyury/T locus have insufficient mesoderm and lack a notochord (Herrmann et al., 1990; Wilkinson et al., 1990). The zebrafish homolog of mouse Brachyury is the loss-of-function mutation no tail (ntl) which, like the mouse, lacks a notochord and is also missing a tail (Halpern et al., 1993; Schulte-Merker et al., 1994). The expression of ntl is expanded by the overexpression of eFGF and inhibited by the overexpression of a dnFGFR (Griffin et al., 1995; Rodaway et al., 1999). As in other species, the expression of Xenopus brachyury (Xbra), a pan-mesodermal marker, is regulated by Fgf signals (Smith et al., 1991; Isaacs et al., 1994; Latinkic et al., 1997). The ectopic expression of Xbra leads to the induction of mesoderm in animal cap explants while its loss-of-function results in mesodermal defects (Cunliffe and Smith, 1992; Conlon et al., 1996). The mesoderm inductivity of Xbra can be overcome by overexpression of dnFGFR (Schulte-Merker and Smith, 1995). It has been suggested that Brachyury/ntl is an immediate mediator of Fgf signaling in mesoderm induction. We are interested in identifying other downstream components of the FGF signaling cascade that regulate mesoderm induction. SP1 is a zinc finger transcription factor that is ubiquitously expressed and binds to GC-rich promoter elements to activate the transcription of target genes (Kadonaga et al., 1987). To date, many SP1-related transcription factors have been identified in a variety of species and these constitute an SP1 family (reviewed in Kaczynski et al., 2003). Unlike SP1, some SP1-like genes are expressed in certain types of cells during the development of vertebrate embryos and are involved in specific developmental processes. For example, mouse Sp5 is a recently identified member that is expressed in the primitive streak during gastrulation and later in the notochord, the neural tube and paraxial mesoderm (Harrison et al., 2000; Treichel et al., 2001). Loss-of-function of Sp5 in the T/+ genetic background can enhance the T/+ phenotype in mice, suggesting a genetic interaction between Sp5 and Brachyury (Harrison et al., 2000). Xenopus XSPR-1 and XSPR-2, and zebrafish Bts1, are closely related to Sp5 (Tallafuss et al., 2001; Ossipova et al., 2002). Both XSPR-2 and bts1 are expressed in the mesoderm precursors. These findings suggest that Sp5 and Sp5-related genes may play a role in mesoderm formation during vertebrate embryogenesis. In this study we have identified zebrafish spr2, an ortholog of Xenopus XSPR2. Expression of spr2 occurs in both hypoblast and epiblast cells during late blastulation and early gastrulation, and at later stages in several mesoderm and neural tissues. We demonstrate that spr2 expression is dependent on Fgf, Nodal and Wnt signals, and it is implicated in mesoderm induction during early development in zebrafish embryos. Results Zebrafish spr2 is a member of the SP1 transcription factor family A new SP1-related sequence was initially identified by whole-mount in situ hybridization from a cDNA library as a gene with a restricted expression pattern during early development in zebrafish embryos. An open reading frame of this gene encodes a putative peptide of 357 residues. A BLAST search revealed that the putative peptide had variable degrees of homology with members of the SP1-like transcription factor family. Further BLAST searches of a public database identified seven SP1 family members in the human genome. A phylogenetic analysis of these sequences is shown in Figure 1 spr2 is expressed in mesodermal and ectodermal tissues during embryogenesis The expression pattern of spr2 in zebrafish embryos was examined by whole-mount in situ hybridization. spr2 transcripts can initially be detected at 30% epiboly on the future dorsal side of the embryo (Figure 2
During gastrulation the expression of spr2 further expands towards the dorsal side and along the anteroposterior axis as spr2-positive cells proliferate and move dorsally by convergent extension (Figure 2 During the early segmentation period, one of the major tissues expressing spr2 is the trunk neural crest where spr2 expression overlaps that of the neural crest marker sox9b (Li et al., 2002) (Figure 2 Spr2 positively regulates ntl expression As shown above, the expression domain of the pan-mesodermal marker ntl lies within the spr2 expression domain during late blastulation and early gastrulation. In order to investigate the possibility that spr2 might play a role in mesoderm induction by regulating ntl expression, we explored the potential effect of Spr2 on ntl expression. First we injected synthetic spr2 mRNA into one-cell stage embryos and examined ntl expression at several stages. At the germ ring stage, the expression of ntl in the germ ring was enhanced to a certain extent in the injected embryos (Figure 3
We then studied the effect of Spr2 on ntl expression by blocking the translation of endogenous spr2 mRNA using morpholino-based knockdown technology (Nasevicius and Ekker, 2000). To test the effectiveness of the morpholinos, fertilized eggs were injected with variable amounts of spr2-MO1 or spr2-MO2 in combination with 100 pg of pSpr2-GFP DNA, an expression construct containing a partial 5′ sequence of spr2 cDNA fused in-frame to a GFP coding sequence. At a dose of 5 ng, the spr2-MO2-injected embryos almost lacked green fluorescence from the GFP fusion protein (Figure 3 To further confirm the mesoderm-promoting activity of Spr2, its impact on the expression of snail1 (sna1), which is a lateral mesoderm marker during early gastrulation (Hammerschmidt and Nusslein-Volhard, 1993; Thisse et al., 1993), was investigated. The overexpression of spr2 enhanced sna1 expression in the lateral germ ring at 50% epiboly stage (Figure 3 Spr2 is involved in Fgf-mediated mesoderm induction Because Xbra/ntl expression is an immediate-early response to mesoderm induction and Xbra/Ntl mediates mesoderm induction activity of Fgfs, we wondered whether Spr2 regulates ntl expression by mediating Fgf signaling. To test this possibility, we explored the change in ntl expression following co-injection with spr2-MO2 and fgf mRNA. We tested two zebrafish Fgf molecules, Fgf8 (Reifers et al., 1998) and a new Fgf family member Fgf17b (our unpublished data). At 75% epiboly, all of the embryos injected with 10 pg of fgf17b mRNA showed a significant increase in ntl expression in the presumptive notochord (Figure 4
The effect of co-injecting spr2 mRNA and XFD mRNA, which encodes a dominant negative form of a Xenopus FGF receptor (Amaya et al., 1991), was also investigated. Overexpression of XFD alone typically led to a slightly smaller axial mesoderm domain and an interrupted germ ring domain (indicated by arrows in Figure 4 Spr2 mediates mesoderm induction of the Nodal signal Nodal signaling is a key player in mesoderm induction (Schier and Shen, 2000). As, in Xenopus, the mesoderm induction activity of Activin, also a TGFβ ligand, is relayed by Fgfs (Cornell and Kimelman, 1994; LaBonne and Whitman, 1994), so Fgfs may also act as a second signal to relay Nodal signaling in mesoderm induction. To test this hypothesis, we coexpressed ectopic zebrafish sqt and Xenopus XFD, and examined ntl expression in the zebrafish embryos at 75% epiboly and the bud stages. At both these stages, expression of ntl was considerably expanded in almost all (n > 32) of the embryos injected with 0.5 pg or 0.25 pg of sqt mRNA alone (Figure 5
As demonstrated earlier, Spr2 appears to be an effector of Fgf signaling in mesoderm induction. Thus, we speculated that Spr2 might also mediate mesoderm induction activity of Nodal signal. Therefore, we first tested whether it was possible to inhibit Sqt activity by knocking down Spr2. When co-injected with 0.5 pg sqt mRNA and 5 ng spr2-MO2, the embryos with ntl expansion during gastrulation accounted for ~78% (n > 36), <100% for the sqt mRNA injection alone. If the dose of sqt mRNA for co-injection was reduced to 0.25 pg, the percentage of the embryos with a comparable level of increase in ntl expression further declined to 41.7% (n = 60) and 38% (n = 71) at 75% epiboly and the bud stages (Figure 5 Lefty1 is an antagonist of Nodal signaling (Thisse and Thisse, 1999). We injected embryos with 100 pg mRNA of zebrafish lefty1 and found that 71.8% (n = 39) of the embryos had no detectable ntl expression and the remaining embryos only showed weak ntl expression in the ventral germ ring at 75% epiboly stage (Figure 5 The involvement of Spr2 in mesoderm induction by Nodal signal was confirmed using another mesoderm marker, sna1. Compared to dramatic expansion of sna1 towards the animal pole at 50% epiboly stage after injection with sqt mRNA alone (Figure 6
Expression of Spr2 is dependent on Nodal, Fgf and Wnt signals Since spr2 is expressed in the mesoderm precursors during early gastrulation and is involved in mesoderm induction by Fgf signals, we asked whether spr2 was regulated by Nodal and Fgf signals and mediated their activities in a feedback fashion. We analysed spr2 expression in the zebrafish embryos in which activities of the signals were altered transiently. When injected with 1 pg sqt mRNA, spr2 was induced throughout the blastoderm at 50% epiboly stage (Figure 7
The dorsal epiblast cells of the early gastrula are committed to a neuroectodermal fate. Considering that Wnt signaling contributes to dorsal mesoderm and neural induction (Baker et al., 1999; Sokol, 1999; Wilson et al., 2001), we speculated that spr2 expression in the dorsal epiblast cells might be also dependent on Wnt signaling. To test this hypothesis, we injected the zebrafish embryos with an mRNA encoding mouse Axin that is a negative regulator of the canonical Wnt signaling pathway (Kikuchi, 1999). The injected embryos indeed lacked spr2 transcripts in the dorsal midline and adjacent areas at 75% epiboly (Figure 7 Discussion spr2/XSPR2 and bts1/XSPR1/Sp5 share similar expression patterns Phylogenetic analysis suggests that spr2/XSPR2 and bts1/XSPR1/Sp5 are duplicated from the same ancestor during evolution. Their expression patterns also share a certain degree of similarity. The expression of spr2 during early gastrulation occurs in the marginal cells, including both epiblast and hypoblast cells, and at later stages in some mesodermal and ectodermal tissues. Like spr2, bts1 is also expressed during early gastrulation in zebrafish (Tallafuss et al., 2001). Unlike spr2, however, bts1 expression is mainly restricted to the epiblast cells of the germ ring with its expression in the dorsal hypoblast layer being restricted to very few cells. This suggests that spr2 and bts1 may have distinct functions in development of the dorsal mesoderm. The dynamic expression of mouse Sp5 is also apparent. During early gastrulation Sp5 is expressed in the primitive streak, including both ectodermal and mesodermal precursors, while in development it is expressed in the midbrain, otic vesicle, the spinal cord, the notochord, somites and even in some endodermal tissues (Harrison et al., 2000; Treichel et al., 2001). Xenopus XSPR-2 appears to be predominantly expressed within the presumptive mesoderm during gastrulation, whereas XSPR-1 expression is restricted to the epithelial and subepithelial layers (Ossipova et al., 2002). The expression patterns of these Sp1 family members are indicative of their functions in the formation and patterning of the mesoderm and/or ectoderm. Spr2 mediates mesoderm induction by Fgf signals Fgf signaling plays several important roles in mesoderm induction during early development of vertebrate embryos (Kimelman and Kirschner, 1987; Slack et al., 1987; Amaya et al., 1991, 1993; Griffin et al., 1995; Reifers et al., 1998). Expression of Brachyury/Xbra/ntl, a T-box transcription factor and a specific mesoderm marker, is an immediate response to Fgf induction and is thus also implicated in mesoderm induction. We have demonstrated, mainly using ntl as a mesoderm marker, that Spr2 is involved in mesoderm induction via the Fgf signaling pathway. First, the overexpression of Spr2 enhances ntl expression, while knockdown of Spr2 activity inhibits ntl expression to a certain degree. Second, the overexpression of Spr2 is able to release the inhibition of XFD on ntl expression. Third, induction of ntl expression by ectopic Fgf is blocked by the simultaneous knockdown of Spr2 activity. However, the extent of increase or decrease in ntl expression caused by overexpression or knockdown of spr2 is not as great as when Fgf or XFD are ectopically expressed, suggesting that multiple effectors may mediate mesoderm induction via Fgf signaling. Individual Sp1-like transcription factors function as activators or repressors, depending on which promoter they bind and the coregulators with which they interact (reviewed by Kaczynski et al., 2003). We have found that the overexpression of spr2 enhances ntl expression in the germ ring at the onset of gastrulation and in the presumptive notochord during epiboly, which excludes the possibility that Spr2 acts as a repressor on ntl promoter. However, the overexpression of spr2 is unable to induce the ectopic expression of ntl in domains where ntl is not normally expressed, and when Spr2 is knocked down then ntl expression is not completely blocked. This implies that Spr2 is involved in the maintenance rather than activation of ntl expression. Mouse embryos that are homozygous for a targeted mutation in Sp5 show no obvious phenotype (Harrison et al., 2000). Nevertheless, the homozygous mutant mice in a genetic background with a deletion of one Brachyury allele have defects in the mesoderm-derived vertebrae, which are not observed in mice with a single mutation. This observation at least suggests that Sp5 genetically interacts with Brachyury to affect development of the mesodermal tissues. Zebrafish spr2 is expressed in the epiblast layer during gastrulation and in some neuronal cells at later stages. Our preliminary study has found that spr2 positively regulates transcription of a posterior neuroectodermal marker hoxb1b and might mediate posteriorization of the neuroectoderm during gastrulation via the Fgf signaling pathway (data not shown). Brachyury/Xbra/ntl may be a direct target of Spr2 Analysis of the mouse Brachyury promoter has found binding sites for Sp1 and Sp4, and the deletion of these sites together with the GATA and Pea3 sites reduces reporter gene expression in embryonal carcinoma P19 cells (Yamaguchi et al., 1999). In the Xbra2 promoter a GC box (GCTGGGGGGGGGGGGGTG), a potential cis-element recognized by Sp1 family members, can be found between –250 and –267. Latinkic et al. (1997) have reported that the 381 bp proximal region of the Xbra2 promoter can elicit responses to Fgf and Activin, whereas the 231 bp promoter, which loses the GC box, fails to respond to Fgf and Activin induction, suggesting requirement of the GC box for such induction. However, further biochemical and molecular studies are needed to confirm the role of Sp1-like factors in transcriptional regulation of Brachyury/Xbra/ntl. Nodal-mediated mesoderm induction is dependent on the action of Fgfs Nodal proteins have been found to be essential for the development of mesoderm in vertebrates (Schier and Shen, 2000). In this study, we have demonstrated that, like Fgf, the overexpression of sqt greatly induces the ectopic expression of ntl and this induction can be effectively inhibited by the coexpression of XFD, suggesting that action of Nodal signaling depends on the action of Fgf signaling. This is consistent with the findings in Xenopus that mesoderm induction by Activin depends on Fgf (Cornell and Kimelman, 1994; LaBonne and Whitman, 1994). The fact that induction of ntl and sna1 expression by ectopic Sqt can be reduced by knocking down Spr2 activity, and that the inhibition of ntl and sna1 expression by the nodal-antagonist lefty1 can be restored by the overexpression of spr2, supports the idea that Spr2 mediates mesoderm induction of Nodal signaling by acting downstream of Fgf signaling during early embryogenesis. Materials and methods Isolation of spr2 cDNAs spr2 was first identified from a zebrafish cDNA library as described in Zhao et al. (2002). The sequence of spr2 was deposited in GenBank with an accession number AY338748. Generation of constructs The coding sequence of spr2 was amplified by PCR with a pair of specific primers and cloned into an expression vector pXT7 to generate construct pXT7-spr2 for in vitro synthesis of spr2 mRNA. The coding sequence of fgf17b, a new member of Fgf family identified in our laboratory (unpublished results), was similarly cloned to generate pXT7-fgf17b. A recombinant pSpr2-GFP plasmid was constructed by inserting a 787 bp fragment of spr2, which contains a 325 bp 5′ UTR and its adjacent coding sequence encoding the first 124 amino acids, in-frame into vector peGFP-N2. This plasmid was used to test the effectiveness of spr2-MO. A GFP coding sequence plus the SV40 polyadenylation signal sequence were cloned into pBluescript KS(–). GFP mRNA was synthesized from the resulting plasmid and was used as an internal injection control. Morpholino oligonucleotides Two antisense morpholino oligonucleotides, spr2-MO1 (5′-CCG CGCTGTTGCTCCTGTTTTTCTG-3′) and spr2-MO2 (5′- CCCCCT TACACAGCCAGGTGCGTAC-3′), were designed to target spr2 mRNA and synthesized by Gene Tools, LLC. Co-injection of spr2-MO1 or spr2-MO2 with pSpr2-GFP DNA revealed that spr2-MO2 was much more effective and so this alone was used for all subsequent experiments. Another morpholino oligonucleotide with the sequence 5′- CTG CTGTAACTACGACCATTTTTGT-3′, which is unrelated in sequence to spr2 and produces no morphological or molecular changes after injection, was used as a control. In vitro synthesis of mRNA Linearized plasmids were used as templates for in vitro transcription using an appropriate Cap-Scribe Kit (Roche). The synthesized mRNA was purified using the RNAeasy@ Mini Kit (Qiagen) after treatment with RNase-free DNase and dissolved in nuclease-free water. Injection DNA or mRNA was diluted in 0.1 M KCl to an appropriate concentration prior to injection, while the morpholino oligonucleotides were diluted in 1× Danieau’s buffer. DNA was injected into the cytoplasm of embryos at the one-cell stage, while the RNAs and morpholinos were injected into the yolk or cytoplasm between the one- and two-cell stages. Injection with GFP mRNA was performed to confirm the effects of overexpression of spr2 or other genes. The injection dose was an estimated amount received by a single embryo. For co-injection of two mRNAs, they were mixed prior to injection. For co-injection of an mRNA with a morpholino (not RNase-free), an embryo was first injected with the mRNA, followed by a second injection with the morpholino. Data obtained from independent micro-injections were pooled. Whole-mount in situ hybridization and histological sectioning Digoxigenin-UTP- or fluorescein-UTP-labeled antisense RNA probes were generated by in vitro transcription. Whole-mount in situ hybridizations essentially followed the standard protocol with minor modifications. Some of the embryos were sectioned at a thickness of ~10 µm. Supplementary data Supplementary data are available at The EMBO Journal Online. Acknowledgements We thank Drs S.Lin, M.R.Rebagliati, B.Thisse, S.C.Lin and J.S.Eisen for kindly providing plasmids. We are also grateful to Dr Sarah Webb for helpful comments. This work was supported by NSFC grants (30270690, 30221003 and 30025020), the ‘863’ Program (2001AA221241), and TRAPOYT of the MOE. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
Development. 2000 Nov; 127(21):4681-9.
[Development. 2000]Cell. 1998 Aug 21; 94(4):515-24.
[Cell. 1998]Development. 1999 Dec; 126(24):5759-70.
[Development. 1999]Development. 1999 Nov; 126(21):4903-11.
[Development. 1999]Development. 2000 Mar; 127(6):1173-83.
[Development. 2000]Genes Dev. 1999 Jul 15; 13(14):1834-46.
[Genes Dev. 1999]Cell. 1987 Dec 4; 51(5):869-77.
[Cell. 1987]Nature. 1987 Mar 12-18; 326(6109):197-200.
[Nature. 1987]Cell. 1991 Jul 26; 66(2):257-70.
[Cell. 1991]Development. 1993 Jun; 118(2):477-87.
[Development. 1993]Development. 1994 Feb; 120(2):453-62.
[Development. 1994]Development. 1994 Feb; 120(2):463-72.
[Development. 1994]Nature. 1990 Feb 15; 343(6259):617-22.
[Nature. 1990]Nature. 1990 Feb 15; 343(6259):657-9.
[Nature. 1990]Cell. 1993 Oct 8; 75(1):99-111.
[Cell. 1993]Cell. 1987 Dec 24; 51(6):1079-90.
[Cell. 1987]Genome Biol. 2003; 4(2):206.
[Genome Biol. 2003]Dev Biol. 2000 Nov 15; 227(2):358-72.
[Dev Biol. 2000]Mech Dev. 2001 Mar; 101(1-2):175-9.
[Mech Dev. 2001]Development. 2001 Oct; 128(20):4021-34.
[Development. 2001]Genome Biol. 2003; 4(2):206.
[Genome Biol. 2003]Mech Dev. 2002 Jul; 115(1-2):117-22.
[Mech Dev. 2002]Development. 2001 Oct; 128(20):4021-34.
[Development. 2001]Dev Biol. 2000 Nov 15; 227(2):358-72.
[Dev Biol. 2000]Development. 1994 Apr; 120(4):1009-15.
[Development. 1994]Development. 1990 Apr; 108(4):581-94.
[Development. 1990]Development. 1996 Mar; 122(3):735-46.
[Development. 1996]Development. 1991 Dec; 113(4):1193-206.
[Development. 1991]Dev Genes Evol. 2002 May; 212(4):203-6.
[Dev Genes Evol. 2002]Proc Natl Acad Sci U S A. 1995 Nov 7; 92(23):10713-7.
[Proc Natl Acad Sci U S A. 1995]Nat Genet. 2000 Oct; 26(2):216-20.
[Nat Genet. 2000]Development. 1993 Dec; 119(4):1107-18.
[Development. 1993]Development. 1993 Dec; 119(4):1203-15.
[Development. 1993]Development. 1998 Jul; 125(13):2381-95.
[Development. 1998]Cell. 1991 Jul 26; 66(2):257-70.
[Cell. 1991]Nature. 2000 Jan 27; 403(6768):385-9.
[Nature. 2000]Development. 1994 Feb; 120(2):453-62.
[Development. 1994]Development. 1994 Feb; 120(2):463-72.
[Development. 1994]Development. 1999 Jan; 126(2):229-40.
[Development. 1999]Cell. 1999 Apr 2; 97(1):121-32.
[Cell. 1999]Curr Opin Genet Dev. 1999 Aug; 9(4):405-10.
[Curr Opin Genet Dev. 1999]Nature. 2001 May 17; 411(6835):325-30.
[Nature. 2001]Cell Signal. 1999 Nov; 11(11):777-88.
[Cell Signal. 1999]Development. 2001 Oct; 128(20):4021-34.
[Development. 2001]Dev Biol. 2000 Nov 15; 227(2):358-72.
[Dev Biol. 2000]Mech Dev. 2001 Mar; 101(1-2):175-9.
[Mech Dev. 2001]Mech Dev. 2002 Jul; 115(1-2):117-22.
[Mech Dev. 2002]Cell. 1987 Dec 4; 51(5):869-77.
[Cell. 1987]Nature. 1987 Mar 12-18; 326(6109):197-200.
[Nature. 1987]Cell. 1991 Jul 26; 66(2):257-70.
[Cell. 1991]Development. 1993 Jun; 118(2):477-87.
[Development. 1993]Development. 1995 Sep; 121(9):2983-94.
[Development. 1995]Genome Biol. 2003; 4(2):206.
[Genome Biol. 2003]Dev Biol. 2000 Nov 15; 227(2):358-72.
[Dev Biol. 2000]Biochem Biophys Res Commun. 1999 Jan 27; 254(3):542-7.
[Biochem Biophys Res Commun. 1999]Genes Dev. 1997 Dec 1; 11(23):3265-76.
[Genes Dev. 1997]Nature. 2000 Jan 27; 403(6768):385-9.
[Nature. 2000]Development. 1994 Feb; 120(2):453-62.
[Development. 1994]Development. 1994 Feb; 120(2):463-72.
[Development. 1994]